{"text": "Supplementary Material\n\nSupplementary Figures\n\nFigure S1. Report frequencies of gene-associated ARVDILI in PubMed and Scopus databases. The reports were searched up to 14 January 2022 and separated according to studied ethnicity.\n\nFigure S2. Protein-protein interaction network of the gene associated ARVDILI with high interaction score of higher than 0.7. Each node represents each protein in this pathway.\n\nFigure S3. Funnel plot of the comparison between CYP2B6 variance and wild-type and the susceptibility of EFV-induced liver injury from 3 publications. (A) Funnel plot of the comparison between CYP2B6 *1/*1 and *1/*6. (B) Funnel plot of the comparison between CYP2B6 *1/*1 and *6/*6. (C) Funnel plot of the comparison between CYP2B6 *1/*1 and *1/*6 plus *6/*6\n\nFigure S4. Funnel plot of the comparison between CYP2B6 variance and wild-type and the susceptibility of NVP-induced liver injury from 2 publications. (A) Funnel plot of the comparison between CYP2B6 *1/*1 and *1/*6. (B) Funnel plot of the comparison between CYP2B6 *1/*1 and *6/*6. (C) Funnel plot of the comparison between CYP2B6 *1/*1 and *1/*6 plus *6/*6\n\nSupplementary table\n\nTable S1. Publication appraisal using The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control/Cohort study\n\nNo \u2028Author \u2028Year \u2028Study design \u2028Selection \u2028Comparability \u2028Exposure/Outcome \u2028Total \u2028 \u2029 \u2028 \u2028 \u2028 \u20281 \u20282 \u20283 \u20284 \u20285 \u20286 \u20287 \u20288 \u20289 \u2028 \u20291 \u2028Yimer et al. (24) \u20282011 \u2028Case-control \u2028* \u2028* \u2028* \u2028* \u2028** \u2028* \u2028* \u2028 \u20288 \u2028 \u20292 \u2028Yimer et al. (23) \u20282012 \u2028Cohort \u2028* \u2028* \u2028* \u2028* \u2028** \u2028* \u2028* \u2028* \u20289 \u2028 \u20293 \u2028Mugusi et al. (21) \u20282012 \u2028Cohort \u2028* \u2028* \u2028* \u2028* \u2028** \u2028* \u2028* \u2028* \u20289 \u2028 \u20294 \u2028Carr et al. (22) \u20282014 \u2028Case-control \u2028* \u2028* \u2028* \u2028* \u2028 \u2028* \u2028* \u2028 \u20286 \u2028 \u20295 \u2028Giacomelli et al. (25) \u20282018 \u2028Case-control \u2028* \u2028* \u2028* \u2028* \u2028** \u2028* \u2028* \u2028* \u20289 \u2028 \u2029"}